CLINICAL_TRIALS
trial_result
· 2012-07-11
Clinical Trial Update: Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy [Phase 2]
Summary
Phase 2 safety and efficacy study of catumaxomab for ovarian cancer after a complete response to chemotherapy has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neovii Biotech | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-07-11